Immunohistochemistry was used to detect the expression of FcγRIIB in mouse xenograft tumors (Fig. 9A), and it was found that IL-4 significantly enhanced the expression of FcγRIIB in subcutaneous tumor interstitial tissue (Fig. 9B). Here, FCGR2B is linked to neoplasm.